Company: KNRX
Filing Date: 2025-01-15
Form Type: F-1/A
Source: 0001493152-25-002249
Chunk: 77

Company: KNOREX LTD.
Filing Date: 2025-01-15
Form: F-1/A
Chunk 77
---
 SG. In consideration thereof, the Company had allotted and issued
an aggregate of 22,477,825 Class A Ordinary Shares and 4,780,555 Class B Ordinary Shares of the Company to the shareholders of Knorex
SG and certain other persons, in accordance with and subject to the terms of the Restructuring Agreement.

Pursuant to the
Restructuring Agreement, the Company also issued warrants to shareholders of the Company, who were previously
shareholders of Knorex SG, and certain other persons in exchange for warrants previously issued to them by Knorex SG. The warrants
issued by the Company included: (i) a total of 4,692,100 warrants with an aggregate amount of US$7,722,941 and (ii) a set of
warrants with an aggregate amount of US$836,597, both exercisable for the same type of securities the Company issues in its
next immediate equity financing round that involves the issuance of preference shares or preferred securities in the Company to
raise funds for the Company (or Class A Ordinary Shares if such immediate equity financing round is our Company’s initial
public offering). In January 2025, a total of 164,713 warrants described in (i) above were exercised to subscribe for 164,713 Class A Ordinary Shares with the remaining 4,527,387 warrants having been cancelled in exchange for the issuance of a total of 4,527,387 warrants with an aggregate amount of US$7,073,397.74 to extend the expiration dates to a period range from March 2026 to December 2027. The expiration dates
of the warrants described in (ii) range from
December 2024 to December 2026. The exercise price for the warrants described in (ii) above with an aggregate amount of US$836,597
shall be determined by reference to the issue price of the types of securities and shall be equal to the issue price of the
securities being offered in the next immediate equity funding round (or equal to 70% of the issue price of Class A Ordinary Shares
if the next immediate equity funding round is the Company’s initial public offering), subject to adjustment for certain
dilutive events such as, among other things, subdivision, reclassification, redenomination, conversion or consolidation of
securities, capitalization, capital distribution, and rights issue. The maximum number of shares that each of these warrant holders
may subscribe for shall be determined by